|
Video: Compound Annual Growth Rate (CAGR) Definition
|
|
Date |
Open |
High |
Low |
Close |
Volume |
03/22/2024 |
$3.92 |
$4.05 |
$3.85 |
$3.92 |
381.40K | 03/25/2024 |
$3.92 |
$4.16 |
$3.92 |
$4.08 |
489.70K | 03/26/2024 |
$4.12 |
$4.25 |
$4.11 |
$4.11 |
486.90K | 03/27/2024 |
$4.17 |
$4.23 |
$4.06 |
$4.16 |
379.80K | 03/28/2024 |
$4.17 |
$4.26 |
$4.17 |
$4.24 |
339.80K |
|
CorMedix is a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of life-threatening diseases and conditions. Co.'s primary focus is on the development of its primary product candidate, DefenCath, for potential commercialization in the U.S. and other main markets. Co. has in-licensed the worldwide rights to develop and commercialize DefenCath and Neutrolin®. DefenCath is an anti-infective solution intended for the reduction of catheter-related infections and thrombosis in patients requiring central venous catheters in clinical settings such as hemodialysis, total parenteral nutrition and oncology. | |
|
CorMedix (CRMD) has the following price history information. Looking back at CRMD historical stock prices for the last five trading days, on March 22, 2024, CRMD opened at $3.92, traded as high as $4.05 and as low as $3.85, and closed at $3.92. Trading volume was a total of 381.40K shares. On March 25, 2024, CRMD opened at $3.92, traded as high as $4.16 and as low as $3.92, and closed at $4.08. Trading volume was a total of 489.70K shares. On March 26, 2024, CRMD opened at $4.12, traded as high as $4.25 and as low as $4.11, and closed at $4.11. Trading volume was a total of 486.90K shares. On March 27, 2024, CRMD opened at $4.17, traded as high as $4.23 and as low as $4.06, and closed at $4.16. Trading volume was a total of 379.80K shares. On March 28, 2024, CRMD opened at $4.17, traded as high as $4.26 and as low as $4.17, and closed at $4.24. Trading volume was a total of 339.80K shares.
CRMD Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into CorMedix shares, starting with a $10,000 purchase of CRMD, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
04/01/2014 |
|
End date: |
03/28/2024 |
|
Start price/share: |
$11.90 |
|
End price/share: |
$4.24 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-64.37% |
|
Average Annual Total Return: |
-9.81% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$3,562.11 |
|
Years: |
10.00 |
|
|
|
Date |
Close |
03/22/2024 | $3.92 | 03/25/2024 | $4.08 | 03/26/2024 | $4.11 | 03/27/2024 | $4.16 | 03/28/2024 | $4.24 |
|
|